Kate Musler: 2025 Pittsburgh Business Times Woman of Influence Shares Passion for Work in the Health Insurance Industry at Highmark Podcast Por  arte de portada

Kate Musler: 2025 Pittsburgh Business Times Woman of Influence Shares Passion for Work in the Health Insurance Industry at Highmark

Kate Musler: 2025 Pittsburgh Business Times Woman of Influence Shares Passion for Work in the Health Insurance Industry at Highmark

Escúchala gratis

Ver detalles del espectáculo

Acerca de esta escucha

Joyce welcomes fellow Pittsburgh Business Times Woman of Influence recipient, Kate Musler, to the show. Kate is Highmark Health’s Chief Financial Officer and will share her responsibilities in that role, and what drives her to help Highmark continue to be a leader in the healthcare insurance industry.

Joyce A. Bender Career Highlights
Serves as CEO of Bender Consulting Services, Inc. and Board Chair and Founder of Bender Leadership Academy, a non-profit organization focused on addressing the transition to work for youth and young adults with disabilities.
Founding partner of iDisability, an eLearning solution.
Named a 2024 Woman of Influence by The Pittsburgh Business Times and 2024 Henry Viscardi Achievement Award Recipient from the Viscardi Center.
Recipient of the 2024 Visionary Award from the Bazelon Center for Mental Health Law in Washington, DC.
Lives with epilepsy and hard of hearing.
Advocates for competitive employment for people with disabilities.
Serves as vice-chair of the American Association of People with Disabilities (AAPD) and former chair of the board.
Represented the State Department in programming with Panama, South Korea, Indonesia, Japan, Kazakhstan, Libya, and Tunisia.
Serves as chair of Epilepsy Association of Western and Central PA.
Received the 2003 New Freedom Initiative Award from the Bush Administration.
Recognized with the 1999 President’s Award from President Clinton.
Board member of Pittsburgh’s Civic Light Opera, the Bazelon Center for Mental Health Law, and World Institute on Disability (WID).

Todavía no hay opiniones